Gene253NCBI Gene
ALS3: amyotrophic lateral sclerosis 3 (autosomal dominant)
Cite this record
ConductScience Library. ALS3: amyotrophic lateral sclerosis 3 (autosomal dominant). Genes, record 253. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/253
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
- Symbol
- ALS3
- Name
- amyotrophic lateral sclerosis 3 (autosomal dominant)
- NCBI Gene ID
- 253
- Aliases
- ALS6
- Type
- unknown
Source NCBI Gene
NIH grants203
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ALS3 papers | Newest fiscal year |
|---|---|---|---|
| R37DE022550 | Host and Fungal Regulation of Type 17 Immunity to Oral Candidiasis | 5 | 2025 |
| R01AI163007 | Regulation and function of mucosal IgA immune responses to mycobiota in the gut. | 3 | 2025 |
| R01AI063503 | Novel Toxins and Receptors in Mucormycosis Pathogenesis and Treatment | 2 | 2025 |
| R01DK113136 | Commensal fungal communities in the regulation of immunity and intestinal inflammation | 2 | 2025 |
| UL1TR001881 | UCLA Clinical and Translational Science Institute | 2 | 2025 |
| ZIAAI001175 | Immunopathogenesis of Fungal Infections | 2 | 2025 |
| P20GM103430 | Rhode Island IDeA Network of Biomedical Research Excellence | 1 | 2025 |
| P30AI045008 | Penn Center for AIDS Research | 1 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 1 | 2025 |
| P30CA062203 | Cancer Center Support Grant | 1 | 2025 |
Source NIH's project files
Papers312
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anticandidal, molecular docking, antioxidant, and cytotoxic effects of the essential oil of Vitex gardneriana Schauer. | An Acad Bras Cienc | 2026 | 42659526 | PubTator, text mining | PubMed |
| Fungal extracellular vesicles as biomarkers in candidiasis: biogenesis, virulence, and CNS diagnostic applications. | Front Cell Dev Biol | 2026 | 42602029 | PubTator, text mining | PubMed |
| Antifungal and anti-biofilm activity of doxepin against Candida spp. mediated by oxidative stress and modulation of adhesion-related genes. | Microb Pathog | 2026 | 42508701 | PubTator, text mining | PubMed |
| Candida albicans hyphae modulate Staphylococcus aureus cell-free supernatant during dual biofilm growth to drive molecular signatures of oral dysplasia. | Med Microbiol Immunol | 2026 | 42319510 | PubTator, text mining | PubMed |
| Effect of postbiotics on biofilm formation and gene expression in Candida spp. isolates from patients with recurrent vulvovaginal candidiasis. | Med Mycol | 2026 | 42275129 | PubTator, text mining | PubMed |
| Immune-Based Prevention and Therapy Against Coccidioidomycosis: Current and Emerging Approaches. | J Fungi (Basel) | 2026 | 41893146 | PubTator, text mining | PubMed |
| State-of-the-Art Review: Managing Vulvovaginal Candidiasis. | Clin Infect Dis | 2026 | 41839452 | PubTator, text mining | PubMed |
| Avian Candidiasis: A Comprehensive Review of Pathogenesis, Diagnosis, and Control. | Vet Sci | 2026 | 41745965 | PubTator, text mining | PubMed |
| The Role of Mucins in Esophageal Inflammatory Diseases. | J Pers Med | 2026 | 41745385 | PubTator, text mining | PubMed |
| Therapeutic Tools for Vulvovaginal Candidiasis: Current and Emerging Antifungal Agents. | J Fungi (Basel) | 2026 | 41745294 | PubTator, text mining | PubMed |
None in this release
- Proteins
- Patents
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/253
GET https://conductscience.org/api/genes/v1/253/grants?page=2